Home・Elenco Azioni・AnaptysBio Inc

AnaptysBio Inc

Aperta

SettoreSettore sanitario

55.79 -2.45

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

55.16

Massimo

57.46

Metriche Chiave
By Trading Economics
Entrata	-102M -53M
Vendite	-83M 26M
EPS	-1.34
Margine di Profitto	-206.934
Dipendenti	104
EBITDA	-99M -31M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+49.73% upside

Dividendi
By Acuity
Utili prossimi	15 set 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-295M 1.7B
Apertura precedente	58.24
Chiusura precedente	55.79

Notizie sul Sentiment di mercato

By Acuity

50%

135 / 339 Classifica in Healthcare

AnaptysBio Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 set 2026, 20:09 UTC

AnaptysBio Inc shares are declining today, briefly recovering earlier in the session before falling sharply and nearing the lower end of its one-month range.

28 ago 2026, 20:07 UTC

AnaptysBio Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. A notable low was seen earlier in the session.

27 ago 2026, 23:01 UTC

AnaptysBio Inc shares are lower in after-market trading, continuing a decline over the past three sessions with no specific news identified.

26 ago 2026, 23:21 UTC

AnaptysBio Inc shares are lower in after-market trading, reflecting increased volatility despite being above its 20-day moving average and near a one-month range high.

25 ago 2026, 19:46 UTC

AnaptysBio Inc shares are lower during Tuesday's session, pulling back from earlier highs amid a lack of specific news to explain the decline.

24 ago 2026, 23:01 UTC

AnaptysBio Inc shares are lower in after-market trading, reaching their lowest point of the day amid broader market concerns over geopolitical tensions and inflation.

21 ago 2026, 19:46 UTC

AnaptysBio Inc shares are higher today, reflecting positive market momentum. The stock has pulled back from an earlier session high but remains up since Thursday.

20 ago 2026, 20:06 UTC

AnaptysBio Inc shares are lower today, continuing a decline since Wednesday amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

19 ago 2026, 19:26 UTC

AnaptysBio Inc shares are higher during Wednesday's session, trading above Tuesday's close and near the upper end of their one-month range. No specific news was identified.

17 ago 2026, 19:56 UTC

News

AnaptysBio Inc shares are higher following significant institutional buying, including a 283.2% increase by Bank of America Corp in Q1 2026.

14 ago 2026, 21:01 UTC

AnaptysBio Inc shares are lower in after-market trading, reflecting broader market weakness amid disappointing U.S. retail sales data and concerns over consumer demand.

12 ago 2026, 19:26 UTC

AnaptysBio Inc shares are lower today, continuing a decline since Tuesday's close, despite earlier intraday gains. No specific news was identified for the movement.

11 ago 2026, 19:36 UTC

AnaptysBio Inc shares are higher today, reflecting an upward movement of over 2% since Monday's close amid notable intraday volatility.

10 ago 2026, 19:46 UTC

AnaptysBio Inc shares are lower today, continuing a decline since Friday. Broader market sentiment is influenced by recent labor market data.

7 ago 2026, 19:26 UTC

AnaptysBio Inc. shares are trading higher today, continuing a trend since Thursday's close, despite notable volatility during the session.

5 ago 2026, 19:36 UTC

AnaptysBio Inc. shares are lower in Wednesday's session, having declined from earlier highs amid routine market fluctuations and trading near the lower end of its recent range.

3 ago 2026, 20:06 UTC

AnaptysBio Inc shares are higher today, recovering from earlier losses amid a broader market rally in the S&P 500 and Nasdaq 100 indices.

31 lug 2026, 20:06 UTC

AnaptysBio Inc shares are lower, reflecting broader market weakness amid rising Treasury yields and crude oil prices, with no specific company news identified.

30 lug 2026, 23:36 UTC

AnaptysBio Inc. shares declined after-market, reflecting ongoing weakness amid broader market volatility and the Federal Reserve's interest rate decisions.

29 lug 2026, 19:56 UTC

Macro Event

AnaptysBio Inc shares are higher, recovering from an earlier dip, amid market volatility following the Federal Reserve's decision to maintain interest rates steady.

28 lug 2026, 23:16 UTC

AnaptysBio Inc shares are higher in after-market trading, recovering from earlier lows. No specific news was identified to explain the movement.

24 lug 2026, 19:16 UTC

AnaptysBio Inc shares are lower today, reflecting a decline since Thursday. Broader market sentiment is affected by recent volatility in oil prices.

23 lug 2026, 09:16 UTC

AnaptysBio Inc is trading lower in pre-market hours amid broader market pressures from disappointing earnings reports and rising geopolitical tensions.

22 lug 2026, 22:16 UTC

AnaptysBio Inc shares are higher in after-market hours, trading above Wednesday's close amid broader market concerns over rising crude oil prices and U.S.-Iran tensions.

21 lug 2026, 20:12 UTC

AnaptysBio Inc. shares are lower in after-market trading, continuing a downward trend and positioning the stock below its 20-day moving average.

20 lug 2026, 23:01 UTC

AnaptysBio Inc. shares are higher in after-market trading, reflecting routine activity. The stock remains below its 20-day moving average.

Confronto tra pari

Modifica del prezzo

AnaptysBio Inc Previsione

Obiettivo di Prezzo

By TipRanks

49.73% in crescita

Previsioni per 12 mesi

Media 84.75 USD 49.73%

Alto 95 USD

Basso 75 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per AnaptysBio Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 5 che hanno fornito valutazioni azionarie a AnaptysBio Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

135 / 339 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo AnaptysBio Inc

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.